ASX Updates
NUHEARA CLINICAL TRIAL AND FDA 510(K) PATHWAY UPDATE
Section 708A(5)(e) Notice (cleansing notice)
Appendix 2A – Application for quotation of securities
Appendix 3B – CN Cap Raising & SPP_231221
NUHEARA UNDERTAKES CAPITAL RAISING TO SUPPORT GROWTH
Company Update December 10 2021
Company Update December 7 2021
Nuheara Secures Global Supply Agreement with Sonova
Nuheara Receives $1.74 Million R&D Tax Cash Rebate
Nuheara Clinical Trial and FDA 510(K) Pathway Update
Nuheara to Present at TechOpps 2021 Virtual Investment Conference
